未登录

K

Kishore B. Challagundla

University of Nebraska Medical Center

H指数:26

被引数:2,833

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Editorial: Immunotherapy: up to date progress in childhood and hematological malignancies

FRONTIERS IN ONCOLOGY

IF3.3

2025-03-270

OAAI

The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma

CELL DEATH & DISEASE

IF9.6

2024-06-184

OAAI

SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2024-06-012

OAAI

Ribosomal Protein L11 Recruits miR-24/miRISC To Repress c-Myc Expression in Response to Ribosomal Stress

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2095

OAAI

Past, Present, and a Glance into the Future of Multiple Myeloma Treatment

PHARMACEUTICALS

IF4.8

2023-03-0813

OAAI

Reprogramming of glycolysis by chemical carcinogens during tumor development

SEMINARS IN CANCER BIOLOGY

IF15.7

2022-12-0112

PRE

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-11-117

OAAI

MIR-15A AND MIR-15B MODULATE NATURAL KILLER AND CD8+T-CELL ACTIVATION AND ANTI-TUMOR IMMUNE RESPONSE BY TARGETING PD-L1 IN NEUROBLASTOMA

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-11-070

OA

Immune checkpoint molecules in neuroblastoma: A clinical perspective

SEMINARS IN CANCER BIOLOGY

IF15.7

2022-11-0111

OAAI

The emerging role of non-coding RNAs in the epigenetic regulation of pediatric cancers

非编码rna在儿童癌症表观遗传调控中的新兴作用

SEMINARS IN CANCER BIOLOGY

IF15.7

2022-08-0115

PREAI

miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma

MOLECULAR THERAPY ONCOLYTICS

IF5.3

2022-06-0124

OAAI

New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies

外泌体介导的肿瘤免疫逃逸的新见解: 临床观点和治疗策略

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2021-12-0135

OAAI

Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma

IF3.4

2021-09-2612

OAAI

Exosomal Long Non-coding RNAs: Emerging Players in the Tumor Microenvironment

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2021-03-0149

OAAI

SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-01-0522

OAAI

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges

IF13.3

2021-01-0169

OAAI

Old drugs, new uses: Drug repurposing in hematological malignancies

SEMINARS IN CANCER BIOLOGY

IF15.7

2021-01-0129

PREAI

Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States

FRONTIERS IN PUBLIC HEALTH

IF3.4

2020-07-21271

OAAI

Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2020-01-0196

OAAI

The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities

MOLECULAR ASPECTS OF MEDICINE

IF10.3

2019-12-0124

OAAI